For the cumulative twelve (12) months of the year ended 31 December 2021, the Group’s revenue had increased by RM7.13 million or 10.47% to RM75.26 million as compared to RM68.13 million in the corresponding cumulated quarter ended 31 December 2020. As disclosed in Note A7, the higher revenue was mainly due to the increase in revenue contribution from healthcare products business segment, health food and beverage business segment and laundry services business segment.
The healthcare products business segment recorded a sharp rise in revenue by RM14.64 million or 119.70% to RM26.87 million in the current cumulative quarter ended 31 December 2021, compared to RM12.23 million in the corresponding cumulative quarter ended 31 December 2020. The increase in revenue was mainly due to new sales generated from virus attenuation devices and higher demand for other healthcare products as consumers became more health-conscious under the COVID-19 climate.
The Group’s new health food and beverage business segment also contributed RM3.26 million revenue in the current cumulative quarter ended 31 December 2021, indicates good demand from customers for consumption of our products.
The Group’s laundry services business segment contributed RM0.74 million revenue in the current cumulative quarter, an increase of 4.79% or RM0.03 million compared to RM0.71 million in the corresponding cumulative quarter ended 31 December 2020. The improvement was mainly due to good demand from customers for use of our services.
(v)Penetrate into virus attenuation or reduction devices business BC Medicare Sdn Bhd, a wholly-owned subsidiary company of BCM, had on 23 December 2021 entered into a Manufacturing Agreement (“the Agreement”) with rLoop Limited (“rLoop”), a Hong Kong corporation have received a letter of offer from Euro-China Technology Achievement Transformation (Tianjin) Co Ltd. (“EC Tech”), a company incorporated in China to purchase 100,000 units of virus attenuation devices with a total sale of US$200 million (RM845 million), to manufacture, test, configure, assemble, package and/or ship the virus attenuation devices using photon mediated electrons and emitters under rLoop’s own brand name of “rGuard-rLoop Virus Attenuation Device” (“Product”). A separate Original Equipment Manufacturer (“OEM”) manufacturing agreement between rLoop and BCM is underway. BCM will also be responsible for providing training to EC Tech on the functions and operations of the Products.
The Products can disable the coronavirus in enclosed spaces with up to 99.9% efficacy, enabling users to get back to normal and serve the people in a safe environment.
The Agreement enables the Company to penetrate into virus attenuation devices business that might yield attractive return to the Group. The prospects in respect of the proposed engagement shall deem to be strong and convincible with exponentially growth of the demand reckons amidst the expectation of herd immunity post inoculation program across the world.
@5c0160. Be rationale dear friend... Do you know basic accounting or laws relating to the quoted counter listed in the BURSA... Don't just give the spam about GN3 0r PN17 matter without look at the condition of the said company.. He He.
Equity:
Share capital RM153,570,000 Merger reserves (RM16,049,000) Revaluation reserves RM4,598,000 Warrant reserve RM29,004,000 Other reserve (RM29,004,000)
wistlebower99.... Look at pasukgb, pdz, sanichi, trive, motuche, lambo, vc, mnc and many more.. -----------
Dear wistlebower99.... But as I know, almost all the said counters are the counters that you actively spamming. I think its the logic why both Mickeyc and scenery wrote a coment about you as given below. YOU ARE THE STOCK KILLER FOR ALMOST ALL THE COUNTERS YOU REFERRED TO US.. He He
Please take a look at your postings in your thread account.
wistlebower99 as been claimed by others ABSOLUTELY THE STOCK KILLER.
.....By scenery: Con liar stockraider aka whistlebower99 aka thehoff spamming all penny stocks here n in FB GorengGroupFB. He non stop since early 2021 days n nights, working very hard for syndicates to collect at low n causes all penny stock lost above 5,000% - 10,000%
He use company PP to spam down price even after those have alredi consolidated n RI, until they fall below consol price. Ridiculously. This conman has caused millions of people losing huge yet he say he help newbies.
Those ppl lost until bankrupt, don't commit suicide go 2 find him out n ask him 2 compensate your losses.
All you buggers just impatient. So easy arh...buy today then go up 1c next day for you all arh. Fast eject arh!! You fellas 1c you make also sell for small profit. Be prepared to wait..
Oay time to collect at such low prices. When down nobody wants, it's time to buy !?? Who knows within a year reach 50c when sentiments greatly improve!? Haha... Buy low sell high !!
BCM ALLIANCE BERHAD ("BCM" OR "THE COMPANY") - ACQUISITION OF 4,294,400 ORDINARY SHARES OF BSL CORPORATION BERHAD ("BSL") - DISPOSAL OF 19,849,000 ORDINARY SHARES OF BSL ------ Subsequent to the Transactions, BCM does not hold any ordinary shares (0%) in BSL as BCM had disposed its entire ordinary shares held in BSL.
The Transactions are not expected to have a material effect on the financial gearing of the Company for the financial year ending 31 December 2022 (“FYE 2022”). As disclosed in the Announcement, the Company had gained a total return of approximately RM1.9 million through the Transactions which might lower the Company’s gearing for the FYE 2022. Furthermore, BCM acquired BSL's shares through its internally generated funds without utilising any margin or any other source of funds.
Eagerly waiting for the next 1QR 2022 in May 2022. Want to see how the healthcare businesses (including the sales from the virus attenuation devices) can uplift the revenue and profitabilty of BCMall...
As reported in the last 4QR 2021 report: .... The healthcare products business segment recorded a sharp rise in revenue by RM14.64 million or 119.70% to RM26.87 million in the current cumulative quarter ended 31 December 2021, compared to RM12.23 million in the corresponding cumulative quarter ended 31 December 2020. The increase in revenue was mainly due to new sales generated from virus attenuation devices and higher demand for other healthcare products as consumers became more health-conscious under the COVID-19 climate.
Laundry biz is earning....just they end up use all ur funds to wash back to their pocket money.....all losses in quoted shares slowly show up in next few qtr till dry...:)
changes in loss on disposal of quoted investments amounting to RM17.41 million as well as Employees’ Share Option Scheme-based payment expense of RM2.07 million.....all change to cash into their pocket now...keep repeating story in all others.....pity retailers......:)
The management tried to operate in their incompetent areas and wasted a big portion of the money from PP/RI/ESOS! The core businesses seemed to be still viable; hope the management are aware of where their focus should be..... Look like the PP takers have loss big time with the current share price at $0.03. With more than 2B shares at the moment, consolidation and another round of RI maybe on if the ~$60M continue being eroded due to the Quoted investments!
Every qtr keep loss 10-20 million as loss making in quoted shares by year end can get money from PP,RI again ------ In the past, BCM is not like as you said. He He
BCM Alliance said it had disposed of its entire stake in BSL on the open market between Sept 13, 2021 and Feb 18, 2022 for a total RM8.32 million.
Remarks: Therefore, because of its latest 1QR 2022 which ended on 31 March 2022, therefore all the losses from the disposal of the quoted BSL shares has been accounted for in the 1QR 2022 accounts. No more losses related to the BSL shares innvestment in the next quarterly report.....
Disposal of BSL resulted loss was at $5.51M while the total realized loss was at $17M+. From the cash flow statement, there are $1.331M unrealized loss from quoted investments, will this loss continue to grow.........
Disposal of BSL resulted loss was at $5.51M while the total realized loss was at $17M+. From the cash flow statement, there are $1.331M unrealized loss from quoted investments, will this loss continue to grow......... ---------
Both realised and unrealised loss on quoted investment has been accounted for in the P@L.
We can see from the cash flow statement:
Loss on disposal of quoted investments - realised RM13,659,000 Loss on disposal of quoted investments - unrealised RM 1,331,000 TOTAL LOSS ON DISPOSAL OF QUOTED INVESTMENT RM 14,999,000
From the notes, stated that the loss on disposal of quoted investment was RM14.99 million.
----The Group recorded loss before tax of RM16.04 million in current quarter as compared to profit before tax of RM0.67 million in the corresponding quarter ended 31 March 2021. The decrease in profit before tax of RM16.71 million or 2,508.86% in current quarter was mainly due to the loss on disposal of quoted investments amounting to RM14.99 million as well as Employees’ Share Option Scheme-based payment expense of RM2.07 million.
BSL investment incurred losses? Already expected..long time ago... a co invested in another co.... in unrelated business... someone could be super rich now...
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
MZM2511
4,548 posts
Posted by MZM2511 > 2022-02-24 19:03 | Report Abuse
For the cumulative twelve (12) months of the year ended 31 December 2021, the Group’s revenue had increased by RM7.13 million or 10.47% to RM75.26 million as compared to RM68.13 million in the corresponding cumulated quarter ended 31 December 2020. As disclosed in Note A7, the higher revenue was mainly due to the increase in revenue contribution from healthcare products business segment, health food and beverage business segment and laundry services business segment.
The healthcare products business segment recorded a sharp rise in revenue by RM14.64 million or 119.70% to RM26.87 million in the current cumulative quarter ended 31 December 2021, compared to RM12.23 million in the corresponding cumulative quarter ended 31 December 2020. The increase in revenue was mainly due to new sales generated from virus attenuation devices and higher demand for other healthcare products as consumers became more health-conscious under the COVID-19 climate.
The Group’s new health food and beverage business segment also contributed RM3.26 million revenue in the current cumulative quarter ended 31 December 2021, indicates good demand from customers for consumption of our products.
The Group’s laundry services business segment contributed RM0.74 million revenue in the current cumulative quarter, an increase of 4.79% or RM0.03 million compared to RM0.71 million in the corresponding cumulative quarter ended 31 December 2020. The improvement was mainly due to good demand from customers for use of our services.